• OPEN AN ACCOUNT
Indian Indices
Nifty
15,959.50 124.15
(0.78%)
Sensex
53,668.50 433.73
( 0.81%)
Bank Nifty
34,208.85 267.95
( 0.79%)
Nifty IT
28,123.40 232.75
( 0.83%)
Global Indices
Nasdaq
11,127.85 99.11
(0.90%)
Dow Jones
31,097.26 321.83
(1.05%)
Hang Seng
21,830.35 -29.44
(-0.13%)
Nikkei 225
26,153.81 218.19
(0.84%)
Forex
USD-INR
78.71 -0.10
(-0.13%)
EUR-INR
82.06 -0.19
(-0.23%)
GBP-INR
95.15 -0.10
(-0.10%)
JPY-INR
0.58 0.00
(-0.09%)

EQUITY - MARKET SCREENER

Libas Consumer Products Ltd
Industry :  Textiles - Products
BSE Code
ISIN Demat
Book Value()
538391
INE908V01012
18.4580499
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
LIBAS
18
46.04
EPS(TTM)
Face Value()
Div & Yield %
1.45
10
0.38
 

wipro ltd
Wipro introduces regulatory literature monitoring for pharmaceutical organizations
Dec 15,2021
Wipro has introduced regulatory literature monitoring for pharmaceutical organizations by entering a managed services engagement with Springer Nature.

Drug safety, referred to as Pharmacovigilance (PV), constitutes the detection, collection, prevention, and monitoring of negative effects that may occur because of the use of pharmaceutical products and other drugs. PV departments in Life Sciences organizations, to fulfil drug safety requirements, leverage literature monitoring that includes Annual Reports, Periodic Safety Update Reports, Individual Case Study Report (ICSR) Monitoring, among others